Introduction to the 2nd GMFH World Summit 2013
Video introduction to the 2nd Gut Microbiota For Health World Summit 2013 held in Madrid, 23-24 February, by Professors Fernando Azpiroz and Francisco Guarner.
GMFH Editing Team
GMFH Editing Team
A new study sheds light on how gut microbiota-derived metabolites can influence host immune and metabolic pathways. Focusing on trimethylamine (TMA) and IRAK4 signaling, the findings help clarify the mechanisms linking microbial metabolism with metabolic inflammation and glycemic regulation.
Blastocystis has long been viewed mainly as a marker of parasitic infection. Emerging research reviewed here suggests that its presence is not necessarily linked to disease, but may instead reflect greater microbial diversity and metabolic health in certain contexts.
Alterations in the composition and function of the gut microbiota are recognized as key contributors to the pathophysiology of IBS. In this interview with Prof. Carmelo Scarpignato, we discuss the knowns and unknowns of gut microbiota in IBS, the four levels of gut microbiota manipulation, and examples of microbiota-targeted approaches available for the clinician.
